Reed introduces bill to strengthen cancer research reporting requirements

Friday, May 4, 2012 03:23 PM

Congressman Tom Reed has introduced legislation in the U.S. House of Representatives which strengthens the enforcement mechanisms of the requirement to publicly report results of cancer trials and research conducted with federal grant money. The goal of the legislation is greater sharing of cancer research results in the search for a cure to cancer.

"The more information available to all researchers, the greater the chance that we will someday find a cure for this horrible disease," Reed said. "Public reporting of both positive and negative results will help other research be more effective and less duplicative. Enforcing the reporting requirement will not only lead to more available cancer research data, but also help every taxpayer dollar spent on research go further toward finding a cure."

"We are so excited and thrilled that our Congressman Tom Reed is introducing legislation which is the result of input received at the Cancer Mission 2020 congressional district cancer summits held last summer," said Gary Mervis, chairman and founder of Camp Good Days and Special Times/Cancer Mission 2020. "This legislation is helping us to take a first step forward in our efforts to end cancer by the end of the decade."

Current law requires that the results of cancer research conducted with federal money be publicly reported. However, the enforcement mechanism is very weak and as a result not all of the cancer research conducted is reported. Reed's bill will require that any unreported research be penalized by forcing full repayment of the research grant to the Treasury. In addition, the recipient of the grant will be ineligible for future grants.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

August 25

Verizon Communications enters clinical trial space with technology, network, and cloud and data services

Sponsors look to the power of genomic profiling to screen, enroll patients in trials for targeted therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs